Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
1 hedge funds and large institutions have $0 invested in Onconova Therapeutics, Inc. Warrants in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $17K → $0 (-$17K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.06K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2K |
ONTXW Hedge Fund Activity: Q1 2020 in Review
1 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q1 2020, worth a combined $0 — down 100% from $17K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ONTXW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $4.06K.
- 1 institutional investor held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q1 2020, down from 3 in Q4 2019.
- Funds reported $0 of Onconova Therapeutics, Inc. Warrants stock for Q1 2020, down 100% quarter-over-quarter.
- 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q1 2020 and 2 closed out, a net change of -2 holders.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q1 2020 was UBS Group, an estimated $4.06K sold.
Based on aggregated 13F filings for Q1 2020.